Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Albany Molecular Research Inc (NASDAQ:AMRI)

15.35
Delayed Data
As of 4:00pm ET
 -0.14 / -0.90%
Today’s Change
14.75
Today|||52-Week Range
22.48
-22.67%
Year-to-Date
No recent news for Albany Molecular Research Inc.

Today’s Trading

Previous close15.49
Today’s open15.19
Day’s range15.06 - 15.56
Volume195,312
Average volume (3 months)315,784
Market cap$549.9M
Dividend yield--
Data as of 4:00pm ET, 02/11/2016

Growth & Valuation

Earnings growth (last year)-125.00%
Earnings growth (this year)+46.91%
Earnings growth (next 5 years)+15.30%
Revenue growth (last year)+12.17%
P/E ratioNM
Price/Sales1.86
Price/Book2.09

Competitors

 Today’s
change
Today’s
% change
SGMOSangamo BioSciences ...-0.01-0.20%
KERXKeryx Biopharmaceuti...+0.01+0.31%
RGNXRegenxbio Inc-0.21-1.71%
LXRXLexicon Pharmaceutic...+0.18+2.20%
Data as of 4:00pm ET, 02/11/2016

Financials

Next reporting dateFebruary 17, 2016
EPS forecast (this quarter)$0.36
Annual revenue (last year)$276.6M
Annual profit (last year)-$3.3M
Net profit margin-1.19%

Profile

Sector
Health Services
Industry
Services to the Health Industry
President, Chief Executive Officer &
Director
William S. Marth
Chief Operating Officer
George Svokos
Corporate headquarters
Albany, New York

Forecasts

Partner Offers